New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - bendroflumethiazide 5mg;  ;   - tablet - 5 mg - active: bendroflumethiazide 5mg     excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - opium tincture 1.369%{relative} ((=1.608%w/v) = 0.0165%w/v anhydrous morphine);  ; squill oxymel 3.78%{relative} (as sfm oxymel squill 125:1000 = 1.67%w/v squill) - linctus - active: opium tincture 1.369%{relative} ((=1.608%w/v) = 0.0165%w/v anhydrous morphine)   squill oxymel 3.78%{relative} (as sfm oxymel squill 125:1000 = 1.67%w/v squill) excipient: benzoic acid camphor ethanol honey methyl hydroxybenzoate purified water star anise oil sugar premium liquid tolu syrup - relief from wet, productive and irritating cough (label claim).

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - chlortalidone 25mg;   - tablet - 25 mg - active: chlortalidone 25mg   excipient: colloidal silicon dioxide iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch purified talc - arterial hypertension, essential or nephrogenic or isolated systolic, as primary therapy or in combination with other antihypertensive agents. stable, chronic heart failure of mild to moderate degree (new york heart association, nhya: functional class ii or iii). - oedema of specific origin - oedema due to peripheral (chronic) venous insufficiency; short-term therapy if physical measures prove insufficient. - fluid retention in premenstrual syndrome only if the gain in weight is the main symptom and is well documented. - ascites due to cirrhosis of the liver in stable patients under close control. - oedema due to nephrotic syndrome. - prophylaxis against recurrent calcium oxalate calculi in patients with idiopathic, normocalcaemic hypercalciuria.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - opium tincture 1.369%{relative} (1% as 1.608%w/v = anhydrous morphine 0.0165%w/v);  ; squill oxymel 3.78%{relative} (sfm squill oxymel bp 125:1000 =squill 1.67%w/v) - linctus - active: opium tincture 1.369%{relative} (1% as 1.608%w/v = anhydrous morphine 0.0165%w/v)   squill oxymel 3.78%{relative} (sfm squill oxymel bp 125:1000 =squill 1.67%w/v) excipient: benzoic acid camphor ethanol honey methyl hydroxybenzoate purified water star anise oil sugar premium liquid tolu syrup - demulcent expectorant and cough suppressant (label claim).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - spironolactone 100mg - tablet - 100 mg - active: spironolactone 100mg excipient: erythrosine lactose monohydrate magnesium stearate microcrystalline cellulose peppermint oil polysorbate 80 povidone purified talc quinoline yellow sodium starch glycolate starch sunset yellow fcf - essential hypertension; oedematous conditions including congestive heart failure, cirrhosis of the liver, (with or without ascites) and the nephrotic syndrome; idiopathic oedema; diagnosis and treatment of primary aldosteronism, as adjunctive therapy in malignant hypertension; in hypokalaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - spironolactone 25mg - tablet - 25 mg - active: spironolactone 25mg excipient: erythrosine lactose monohydrate magnesium stearate microcrystalline cellulose peppermint oil polysorbate 80 povidone purified talc quinoline yellow sodium starch glycolate starch sunset yellow fcf - essential hypertension; oedematous conditions including congestive heart failure, cirrhosis of the liver, (with or without ascites) and the nephrotic syndrome; idiopathic oedema; diagnosis and treatment of primary aldosteronism, as adjunctive therapy in malignant hypertension; in hypokalaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate.

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Israel - English - Ministry of Health

teva israel ltd - spironolactone - tablets - spironolactone 100 mg - spironolactone - spironolactone - edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. essential hypertention. primary hyperaldostronism. hypokalemia.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - spironolactone - coated tablets - spironolactone 25 mg - spironolactone - spironolactone - congestive heart failure, cirrhotic ascites.